Abstract

Protein ubiquitination regulates a wide range of cellular processes. The degree of protein ubiquitination is determined by the delicate balance between ubiquitin ligase (E3)-mediated ubiquitination and deubiquitinase (DUB)-mediated deubiquitination. In comparison to the E3-substrate interactions, the DUB-substrate interactions (DSIs) remain insufficiently investigated. To address this challenge, we introduce a protein sequence-based ab initio method, TransDSI, which transfers proteome-scale evolutionary information to predict unknown DSIs despite inadequate training datasets. An explainable module is integrated to suggest the critical protein regions for DSIs while predicting DSIs. TransDSI outperforms multiple machine learning strategies against both cross-validation and independent test. Two predicted DUBs (USP11 and USP20) for FOXP3 are validated by “wet lab” experiments, along with two predicted substrates (AR and p53) for USP22. TransDSI provides new functional perspective on proteins by identifying regulatory DSIs, and offers clues for potential tumor drug target discovery and precision drug application.

The specificity of protein deubiquitination relies on deubiquitinase-substrate interactions (DSIs). Here, authors leverage evolutionary information from the proteome to predict DSIs, even with an inadequate training dataset.

Details

Title
A protein sequence-based deep transfer learning framework for identifying human proteome-wide deubiquitinase-substrate interactions
Author
Liu, Yuan 1 ; Li, Dianke 2   VIAFID ORCID Logo  ; Zhang, Xin 1   VIAFID ORCID Logo  ; Xia, Simin 3   VIAFID ORCID Logo  ; Qu, Yingjie 1   VIAFID ORCID Logo  ; Ling, Xinping 4   VIAFID ORCID Logo  ; Li, Yang 1   VIAFID ORCID Logo  ; Kong, Xiangren 1   VIAFID ORCID Logo  ; Zhang, Lingqiang 1   VIAFID ORCID Logo  ; Cui, Chun-Ping 1   VIAFID ORCID Logo  ; Li, Dong 1   VIAFID ORCID Logo 

 Beijing Institute of Lifeomics, State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072) 
 Beijing Institute of Lifeomics, State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072); China Agricultural University, State Key Laboratory of Farm Animal Biotech Breeding, College of Biological Sciences, Beijing, China (GRID:grid.22935.3f) (ISNI:0000 0004 0530 8290) 
 Beijing Institute of Lifeomics, State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072); Anhui Medical University, School of Basic Medical Sciences, Hefei, China (GRID:grid.186775.a) (ISNI:0000 0000 9490 772X) 
 Beijing Institute of Lifeomics, State Key Laboratory of Medical Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing, China (GRID:grid.419611.a) (ISNI:0000 0004 0457 9072); Hebei University, College of Life Sciences, Baoding, China (GRID:grid.256885.4) (ISNI:0000 0004 1791 4722) 
Pages
4519
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3060941306
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.